Basic Properties of Adipose-Derived Mesenchymal Stem Cells of Rheumatoid Arthritis and Osteoarthritis Patients

Rheumatoid arthritis (RA) and osteoarthritis (OA) are destructive joint diseases, the development of which are associated with the expansion of pathogenic T lymphocytes. Mesenchymal stem cells may be an attractive therapeutic option for patients with RA or OA due to the regenerative and immunomodula...

Full description

Bibliographic Details
Main Authors: Ewa Kuca-Warnawin, Weronika Kurowska, Magdalena Plebańczyk, Anna Wajda, Anna Kornatka, Tomasz Burakowski, Iwona Janicka, Piotr Syrówka, Urszula Skalska
Format: Article
Language:English
Published: MDPI AG 2023-03-01
Series:Pharmaceutics
Subjects:
Online Access:https://www.mdpi.com/1999-4923/15/3/1003
_version_ 1827747977707388928
author Ewa Kuca-Warnawin
Weronika Kurowska
Magdalena Plebańczyk
Anna Wajda
Anna Kornatka
Tomasz Burakowski
Iwona Janicka
Piotr Syrówka
Urszula Skalska
author_facet Ewa Kuca-Warnawin
Weronika Kurowska
Magdalena Plebańczyk
Anna Wajda
Anna Kornatka
Tomasz Burakowski
Iwona Janicka
Piotr Syrówka
Urszula Skalska
author_sort Ewa Kuca-Warnawin
collection DOAJ
description Rheumatoid arthritis (RA) and osteoarthritis (OA) are destructive joint diseases, the development of which are associated with the expansion of pathogenic T lymphocytes. Mesenchymal stem cells may be an attractive therapeutic option for patients with RA or OA due to the regenerative and immunomodulatory abilities of these cells. The infrapatellar fat pad (IFP) is a rich and easily available source of mesenchymal stem cells (adipose-derived stem cells, ASCs). However, the phenotypic, potential and immunomodulatory properties of ASCs have not been fully characterised. We aimed to evaluate the phenotype, regenerative potential and effects of IFP-derived ASCs from RA and OA patients on CD4+ T cell proliferation. The MSC phenotype was assessed using flow cytometry. The multipotency of MSCs was evaluated on the basis of their ability to differentiate into adipocytes, chondrocytes and osteoblasts. The immunomodulatory activities of MSCs were examined in co-cultures with sorted CD4+ T cells or peripheral blood mononuclear cells. The concentrations of soluble factors involved in ASC-dependent immunomodulatory activities were assessed in co-culture supernatants using ELISA. We found that ASCs with PPIs from RA and OA patients maintain the ability to differentiate into adipocytes, chondrocytes and osteoblasts. ASCs from RA and OA patients also showed a similar phenotype and comparable abilities to inhibit CD4+ T cell proliferation, which was dependent on the induction of soluble factors The results of our study constitute the basis for further research on the therapeutic potential of ASCs in the treatment of patients with RA and OA.
first_indexed 2024-03-11T06:00:48Z
format Article
id doaj.art-04e16f30111f41bda5069e92ad75f1b6
institution Directory Open Access Journal
issn 1999-4923
language English
last_indexed 2024-03-11T06:00:48Z
publishDate 2023-03-01
publisher MDPI AG
record_format Article
series Pharmaceutics
spelling doaj.art-04e16f30111f41bda5069e92ad75f1b62023-11-17T13:17:25ZengMDPI AGPharmaceutics1999-49232023-03-01153100310.3390/pharmaceutics15031003Basic Properties of Adipose-Derived Mesenchymal Stem Cells of Rheumatoid Arthritis and Osteoarthritis PatientsEwa Kuca-Warnawin0Weronika Kurowska1Magdalena Plebańczyk2Anna Wajda3Anna Kornatka4Tomasz Burakowski5Iwona Janicka6Piotr Syrówka7Urszula Skalska8Department of Pathophysiology and Immunology, National Institute of Geriatrics, Rheumatology and Rehabilitation, 02-637 Warsaw, PolandDepartment of Pathophysiology and Immunology, National Institute of Geriatrics, Rheumatology and Rehabilitation, 02-637 Warsaw, PolandDepartment of Pathophysiology and Immunology, National Institute of Geriatrics, Rheumatology and Rehabilitation, 02-637 Warsaw, PolandDepartment of Molecular Biology, National Institute of Geriatrics, Rheumatology and Rehabilitation, 02-637 Warsaw, PolandDepartment of Pathophysiology and Immunology, National Institute of Geriatrics, Rheumatology and Rehabilitation, 02-637 Warsaw, PolandDepartment of Pathophysiology and Immunology, National Institute of Geriatrics, Rheumatology and Rehabilitation, 02-637 Warsaw, PolandDepartment of Pathophysiology and Immunology, National Institute of Geriatrics, Rheumatology and Rehabilitation, 02-637 Warsaw, PolandRheumaorthopedics Clinic and Polyclinic, National Institute of Geriatrics, Rheumatology and Rehabilitation, 02-637 Warsaw, PolandDepartment of Pathophysiology and Immunology, National Institute of Geriatrics, Rheumatology and Rehabilitation, 02-637 Warsaw, PolandRheumatoid arthritis (RA) and osteoarthritis (OA) are destructive joint diseases, the development of which are associated with the expansion of pathogenic T lymphocytes. Mesenchymal stem cells may be an attractive therapeutic option for patients with RA or OA due to the regenerative and immunomodulatory abilities of these cells. The infrapatellar fat pad (IFP) is a rich and easily available source of mesenchymal stem cells (adipose-derived stem cells, ASCs). However, the phenotypic, potential and immunomodulatory properties of ASCs have not been fully characterised. We aimed to evaluate the phenotype, regenerative potential and effects of IFP-derived ASCs from RA and OA patients on CD4+ T cell proliferation. The MSC phenotype was assessed using flow cytometry. The multipotency of MSCs was evaluated on the basis of their ability to differentiate into adipocytes, chondrocytes and osteoblasts. The immunomodulatory activities of MSCs were examined in co-cultures with sorted CD4+ T cells or peripheral blood mononuclear cells. The concentrations of soluble factors involved in ASC-dependent immunomodulatory activities were assessed in co-culture supernatants using ELISA. We found that ASCs with PPIs from RA and OA patients maintain the ability to differentiate into adipocytes, chondrocytes and osteoblasts. ASCs from RA and OA patients also showed a similar phenotype and comparable abilities to inhibit CD4+ T cell proliferation, which was dependent on the induction of soluble factors The results of our study constitute the basis for further research on the therapeutic potential of ASCs in the treatment of patients with RA and OA.https://www.mdpi.com/1999-4923/15/3/1003adipose-derived stem cellsrheumatoid arthritisosteoarthritistissue regenerationimmunomodulation
spellingShingle Ewa Kuca-Warnawin
Weronika Kurowska
Magdalena Plebańczyk
Anna Wajda
Anna Kornatka
Tomasz Burakowski
Iwona Janicka
Piotr Syrówka
Urszula Skalska
Basic Properties of Adipose-Derived Mesenchymal Stem Cells of Rheumatoid Arthritis and Osteoarthritis Patients
Pharmaceutics
adipose-derived stem cells
rheumatoid arthritis
osteoarthritis
tissue regeneration
immunomodulation
title Basic Properties of Adipose-Derived Mesenchymal Stem Cells of Rheumatoid Arthritis and Osteoarthritis Patients
title_full Basic Properties of Adipose-Derived Mesenchymal Stem Cells of Rheumatoid Arthritis and Osteoarthritis Patients
title_fullStr Basic Properties of Adipose-Derived Mesenchymal Stem Cells of Rheumatoid Arthritis and Osteoarthritis Patients
title_full_unstemmed Basic Properties of Adipose-Derived Mesenchymal Stem Cells of Rheumatoid Arthritis and Osteoarthritis Patients
title_short Basic Properties of Adipose-Derived Mesenchymal Stem Cells of Rheumatoid Arthritis and Osteoarthritis Patients
title_sort basic properties of adipose derived mesenchymal stem cells of rheumatoid arthritis and osteoarthritis patients
topic adipose-derived stem cells
rheumatoid arthritis
osteoarthritis
tissue regeneration
immunomodulation
url https://www.mdpi.com/1999-4923/15/3/1003
work_keys_str_mv AT ewakucawarnawin basicpropertiesofadiposederivedmesenchymalstemcellsofrheumatoidarthritisandosteoarthritispatients
AT weronikakurowska basicpropertiesofadiposederivedmesenchymalstemcellsofrheumatoidarthritisandosteoarthritispatients
AT magdalenaplebanczyk basicpropertiesofadiposederivedmesenchymalstemcellsofrheumatoidarthritisandosteoarthritispatients
AT annawajda basicpropertiesofadiposederivedmesenchymalstemcellsofrheumatoidarthritisandosteoarthritispatients
AT annakornatka basicpropertiesofadiposederivedmesenchymalstemcellsofrheumatoidarthritisandosteoarthritispatients
AT tomaszburakowski basicpropertiesofadiposederivedmesenchymalstemcellsofrheumatoidarthritisandosteoarthritispatients
AT iwonajanicka basicpropertiesofadiposederivedmesenchymalstemcellsofrheumatoidarthritisandosteoarthritispatients
AT piotrsyrowka basicpropertiesofadiposederivedmesenchymalstemcellsofrheumatoidarthritisandosteoarthritispatients
AT urszulaskalska basicpropertiesofadiposederivedmesenchymalstemcellsofrheumatoidarthritisandosteoarthritispatients